Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics. AMCR 2025, 7 (1), 1-18. https://doi.org/10.37275/amcr.v7i1.831.